|
I Inherited Red Cell Disorders |
|
|
1 | (16) |
|
|
2 | (4) |
|
|
2 | (2) |
|
|
|
|
4 | (2) |
|
|
|
|
6 | (5) |
|
|
6 | (1) |
|
|
|
|
7 | (2) |
|
|
|
|
9 | (1) |
|
|
|
Heinz Body Hemolytic Anemia |
|
|
10 | (1) |
|
|
|
11 | (2) |
|
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency |
|
|
11 | (1) |
|
|
|
Pyruvate Kinase Deficiency |
|
|
12 | (1) |
|
|
|
D Disorders of Heme Synthesis |
|
|
13 | (1) |
|
Sideroblastic Anemia (Congenital and Acquired) |
|
|
13 | (1) |
|
|
|
E Red Cell Membrane Disorders |
|
|
14 | (2) |
|
|
14 | (1) |
|
|
|
Hereditary Elliptocytosis (HE) and Related Disorders |
|
|
15 | (1) |
|
|
|
F Other Congenital Red Cell Disorders |
|
|
16 | (1) |
|
Congenital Dyserythropoietic Anemia (CDA) |
|
|
16 | (1) |
|
|
|
II Acquired Red Cell Disorders |
|
|
17 | (18) |
|
A Red Cell Membrane Disorders |
|
|
18 | (1) |
|
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
|
18 | (1) |
|
|
|
B Nutritional Deficiencies |
|
|
19 | (3) |
|
Iron Deficiency Anemia (IDA) |
|
|
19 | (1) |
|
|
|
Folate and B,12 (Cobalamin) Deficienc |
|
|
20 | (2) |
|
|
|
|
22 | (2) |
|
|
22 | (1) |
|
|
|
Hematologic Complications of Alcoholism |
|
|
23 | (1) |
|
|
|
D Intravascular Hemolysis |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
E Immunologic Destruction |
|
|
25 | (1) |
|
Autoimmune Hemolytic Anemia (AIHA) |
|
|
25 | (1) |
|
|
|
|
26 | (5) |
|
Metastatic Lesions in Bone Marrow Biopsies |
|
|
26 | (3) |
|
|
|
29 | (1) |
|
|
Storage Disorders: Niemann-Pick Disease (NPD) |
|
|
30 | (1) |
|
|
|
31 | (4) |
|
|
31 | (2) |
|
|
|
33 | (2) |
|
|
III Inherited White Cell And Platelet Disorders |
|
|
35 | (6) |
|
|
36 | (1) |
|
|
|
37 | (2) |
|
|
|
39 | (1) |
|
|
|
40 | (1) |
|
|
|
IV Infectious Disorders Seen In Blood |
|
|
41 | (8) |
|
|
42 | (2) |
|
|
|
44 | (1) |
|
|
Ehrlichiosis Anaplasmosis |
|
|
45 | (1) |
|
|
|
46 | (1) |
|
|
|
47 | (2) |
|
|
V Disorders Of Hemostasis |
|
|
49 | (4) |
|
Disseminated Intravascular Coagulation (DIC) |
|
|
50 | (1) |
|
|
Thrombotic Thrombocytopenia Purpura (TTP) Hemolytic Uremic Syndrome (HUS) |
|
|
51 | (2) |
|
|
VI Bone Marrow Failure Syndromes |
|
|
53 | (2) |
|
|
54 | (1) |
|
|
VII Reactive Lymphadenopathies |
|
|
55 | (30) |
|
|
56 | (16) |
|
Tuberculosis and Mycobacterial Lymphadenopathy |
|
|
56 | (3) |
|
|
Cryptococcal Lymphadenitis |
|
|
59 | (2) |
|
|
|
|
61 | (1) |
|
|
|
62 | (1) |
|
|
|
|
63 | (2) |
|
|
Cytomegalovirus (CMV) Infection |
|
|
65 | (2) |
|
|
Herpes Simplex Virus (HSV) Lymphadenitis |
|
|
67 | (2) |
|
|
|
69 | (2) |
|
|
|
71 | (1) |
|
|
|
72 | (5) |
|
|
72 | (2) |
|
|
Systemic Lupus Erythematosus (SLE) Lymphadenopathy |
|
|
74 | (1) |
|
|
Rheumatoid Lymphadenopathy |
|
|
75 | (2) |
|
|
|
77 | (1) |
|
A Hyaline Vascular Variant |
|
|
77 | (2) |
|
|
B Multicentric/Plasma Cell Variant |
|
|
79 | (6) |
|
|
Foreign Body Lymphadenopathy |
|
|
80 | (2) |
|
|
|
Dermatopathic Lymphadenopathy |
|
|
82 | (1) |
|
|
Non-Specific Lymphadenopathy |
|
|
83 | (2) |
|
|
VIII Reactive Histiocytic Disorders |
|
|
85 | (6) |
|
|
86 | (1) |
|
|
|
|
87 | (2) |
|
|
|
Hemophagocytic Lymphohistiocytosis (Primary and Acquired) |
|
|
89 | (2) |
|
|
|
91 | (112) |
|
A Lymphoblastic Neoplasms |
|
|
92 | (4) |
|
B Lymphoblastic Leukemia Lymphoma (B-ALL LBL) |
|
|
92 | (2) |
|
|
|
T Lymphoblastic Leukemia Lymphoma (T-ALL LBL) |
|
|
94 | (2) |
|
|
|
B Mature B-CeLL Neoplasms |
|
|
96 | (8) |
|
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma |
|
|
96 | (2) |
|
|
|
B-Cell Prolymphocytic Leukemia |
|
|
98 | (1) |
|
|
|
99 | (2) |
|
|
Hairy Cell Leukemia---Variant |
|
|
101 | (1) |
|
|
Splenic Marginal Zone Lymphoma |
|
|
102 | (2) |
|
|
|
Extranodal Marginal Zone Lymphoma |
|
|
104 | (1) |
|
A Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) |
|
|
104 | (2) |
|
|
|
B Cutaneous Marginal Zone Lymphoma |
|
|
106 | (39) |
|
|
Nodal Marginal Zone Lymphoma |
|
|
107 | (2) |
|
|
|
Lymphoplasmacytic Lymphoma |
|
|
109 | (2) |
|
|
|
111 | (2) |
|
|
|
|
113 | (3) |
|
|
|
Primary Cutaneous Follicle Center Lymphoma |
|
|
116 | (2) |
|
|
|
118 | (2) |
|
|
Diffuse Large B-Cell Lymphoma (DLBCL), Not Otherwise Specified (Including with Chronic Inflammation) |
|
|
120 | (2) |
|
|
B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Burkitt Lymphoma |
|
|
122 | (2) |
|
|
|
T-Cell/Histiocytic-Rich Large B-Cell Lymphoma |
|
|
124 | (2) |
|
|
B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma (CHL) |
|
|
126 | (2) |
|
|
|
Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the CNS |
|
|
128 | (1) |
|
|
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type |
|
|
129 | (2) |
|
|
EBV-Positive Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly |
|
|
131 | (2) |
|
|
Lymphomatoid Granulomatosis |
|
|
133 | (2) |
|
|
|
Primary Mediastinal Large B-Cell Lymphoma (PMBCL) |
|
|
135 | (2) |
|
|
|
|
137 | (1) |
|
|
|
138 | (1) |
|
|
Large B-Cell Lymphoma Arising in HHV-8-Associated Multicentric Castleman Disease (MCD) |
|
|
139 | (2) |
|
|
Primary Effusion Lymphoma and Related Entities |
|
|
141 | (2) |
|
|
ALK Large B-Cell Lymphoma |
|
|
143 | (2) |
|
|
|
|
145 | (7) |
|
Monoclonal Gammopathy of Undetermined Significance |
|
|
145 | (1) |
|
|
|
146 | (3) |
|
|
|
149 | (1) |
|
|
Immunoglobulin Deposition Diseases |
|
|
150 | (1) |
|
|
|
151 | (1) |
|
|
D Mature T-Cell and NK-Cell Neoplasms |
|
|
152 | (5) |
|
|
152 | (4) |
|
|
|
156 | (1) |
|
|
Primary Cutaneous CD30* T-Cell Lymphoproliferative Disorders |
|
|
157 | (1) |
|
A Lymphomatoid Papulosis (LYP) |
|
|
157 | (2) |
|
|
B Primary Cutaneous Anaplastic Large Cell Lymphoma (ALCL) |
|
|
159 | (18) |
|
|
Primary Cutaneous γ δ T-Cell Lymphoma |
|
|
159 | (4) |
|
|
Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma |
|
|
163 | (2) |
|
|
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoma |
|
|
165 | (2) |
|
|
T-Cell Prolymphocytic Leukemia |
|
|
167 | (1) |
|
|
|
T-Cell Large Granular Lymphocytic Leukemia (T-LGL) |
|
|
168 | (2) |
|
|
Peripheral T-Cell Lymphoma, Not Otherwise Specified |
|
|
170 | (1) |
|
|
|
Angioimmunoblastic T-Cell Lymphoma |
|
|
171 | (2) |
|
|
|
Anaplastic Large Cell Lymphoma, ALK+ |
|
|
173 | (2) |
|
|
Anaplastic Large Cell Lymphoma, ALK- |
|
|
175 | (2) |
|
|
EBV-Positive T-Cell Lymphoproliferative Disorders of Childhood |
|
|
177 | (1) |
|
A Systemic EBV-Positive T-Cell Lymphoproliferative Disease of Childhood |
|
|
177 | (1) |
|
|
|
B Hydroa Vacciniforme-Like Lymphoma |
|
|
178 | (10) |
|
|
|
Adult T-Cell Leukemia/Lymphoma (ATLLJ |
|
|
180 | (2) |
|
|
|
Enteropathy-Associated T-Cell Lymphoma (EATL) |
|
|
182 | (2) |
|
|
|
Hepatosplenic T-Cell Lymphoma |
|
|
184 | (2) |
|
|
Subcutaneous Panniculitis-Like T-Cell Lymphoma |
|
|
186 | (2) |
|
|
|
188 | (4) |
|
Extranodal NK/T-Cell Lymphoma |
|
|
188 | (2) |
|
|
|
Aggressive NK-Cell Leukemia |
|
|
190 | (1) |
|
|
Chronic Lymphoproliferative Disorder of NK Cells |
|
|
191 | (1) |
|
|
F Classical Hodgkin Lymphoma |
|
|
192 | (11) |
|
|
192 | (2) |
|
|
|
194 | (2) |
|
|
|
196 | (2) |
|
|
|
198 | (2) |
|
|
Nodular Lymphocyte-Predominant Hodgkin Lymphoma |
|
|
200 | (3) |
|
|
X Immunodeficiency-Associated Lymphoproliferative Disorders |
|
|
203 | (10) |
|
A HIV-Associated Lymphoproliferative Disorders |
|
|
204 | (3) |
|
|
204 | (2) |
|
|
|
HIV-Associated Lymphoproliferative Disorders |
|
|
206 | (1) |
|
|
|
B Post-Transplant Lymphoproliferative Disorders (PTLDs) |
|
|
207 | (2) |
|
Early, Polymorphic, Monomorphic, and Hodgkin Types |
|
|
207 | (2) |
|
|
C Primary Immunodeficiency-Associated Lymphoproliferative Disorders |
|
|
209 | (4) |
|
Overview of Primary Immunodeficiency-Associated Lymphoproliferative Disorders |
|
|
209 | (1) |
|
|
Autoimmune Lymphoproliferative Syndrome (ALPS) |
|
|
209 | (4) |
|
|
|
213 | (58) |
|
A Myeloproliferative Disorders |
|
|
214 | (14) |
|
Chronic Myelogenous Leukemia (CML) |
|
|
214 | (2) |
|
|
Chronic Neutrophilic Leukemia (CNL) |
|
|
216 | (1) |
|
|
|
217 | (2) |
|
|
|
Essential Thrombocythemia (ET) |
|
|
219 | (1) |
|
|
|
Primary Myelofibrosis (PMF) |
|
|
220 | (2) |
|
|
|
Chronic Eosinophilic Leukemia (CEL) |
|
|
222 | (2) |
|
|
|
|
224 | (4) |
|
|
|
B Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, Or FGFR1 |
|
|
228 | (3) |
|
|
|
C Myelodysplastic Myeloproliferative Neoplasms |
|
|
231 | (5) |
|
Chronic Myelomonocytic Leukemia |
|
|
231 | (2) |
|
|
Atypical Chronic Myeloid Leukemia |
|
|
233 | (2) |
|
|
|
Juvenile Myelomonocytic Leukemia (JMML) |
|
|
235 | (1) |
|
|
D Myelodysplastic Syndromes |
|
|
236 | (5) |
|
Refractory Anemia with Unilineage Dysplasia |
|
|
236 | (1) |
|
|
|
Refractory Anemia with Ring Sideroblasts |
|
|
237 | (1) |
|
|
|
Refractory Cytopenia with Multilineage Dysplasia |
|
|
238 | (1) |
|
|
Refractory Anemia with Excess Blasts (RAEB) |
|
|
239 | (1) |
|
|
|
Myelodysplastic Syndrome (MDS) with Isolated del(5q) |
|
|
240 | (1) |
|
|
E Acute Myeloid Leukemia (AML) with Recurrent Genetic Aberrations |
|
|
241 | (1) |
|
AML with t(8;21)[ qZ2;q22); RUNX1/Runx1T1 |
|
|
241 | (1) |
|
|
Acute Myeloid Leukemia (AML) with inv(16) (p13.1 q22) or t(16;16)(p13.1 ;q22); CBFB-MYH11 |
|
|
242 | (9) |
|
|
Acute Promyelocytic Leukemia with t(15;17) (q22;q12); PML-RARA |
|
|
243 | (2) |
|
|
Acute Myeloid Leukemia (AML) with t(9;1 1) (p22;q23); MLLT3-MLL |
|
|
245 | (1) |
|
|
Acute Myeloid Leukemia (AML) with t(6;9) (p23;q34); DEK-NUP214 |
|
|
246 | (1) |
|
|
Acute Myeloid Leukemia (AML) with inv(3) (q21 q26.6) or t(3;3)(q21;q26.2); RPN1-EVI1 |
|
|
247 | (1) |
|
|
Acute Myeloid Leukemia (AML) (Megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 |
|
|
248 | (1) |
|
|
Acute Myeloid Leukemia (AML) with Mutated NPM1 |
|
|
249 | (1) |
|
|
Acute Myeloid Leukemia (AML) with Mutated CEBPA |
|
|
250 | (1) |
|
|
F Acute Myeloid Leukemia (AML), not Otherwise Specified |
|
|
251 | (12) |
|
AML with Minimal Differentiation |
|
|
251 | (1) |
|
|
Acute Myeloid Leukemia (AML) without Maturation |
|
|
252 | (1) |
|
|
Acute Myeloid Leukemia (AML) with Maturation |
|
|
253 | (1) |
|
|
Acute Myelomonocytic Leukemia |
|
|
254 | (2) |
|
|
Acute Monoblastic Leukemia |
|
|
256 | (2) |
|
|
|
258 | (1) |
|
|
Acute Erythroid Leukemia, Erythroid Myeloid Subtype |
|
|
259 | (2) |
|
|
Acute Erythroid Leukemia, Pure Erythroid Leukemia Subtype |
|
|
261 | (1) |
|
|
Acute Megakaryoblastic Leukemia |
|
|
262 | (1) |
|
|
G Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes |
|
|
263 | (2) |
|
|
H Therapy-Related Myeloid Neoplasms |
|
|
265 | (2) |
|
|
|
267 | (1) |
|
|
|
J Myeloid Proliferation Related to Down Syndrome (DS) |
|
|
268 | (1) |
|
|
K Elastic Plasmacytoid Dendritic Cell Neoplasm |
|
|
269 | (2) |
|
|
XII Histiocytic And Dendritic Cell Neoplasms |
|
|
271 | (12) |
|
|
272 | (1) |
|
|
Langerhans Cell Histiocytosis |
|
|
273 | (2) |
|
|
|
|
275 | (2) |
|
|
Follicular Dendritic Cell Sarcoma |
|
|
277 | (2) |
|
|
Interdigitating Dendritic Cell Sarcoma |
|
|
279 | (1) |
|
|
Indeterminate Dendritic Cell Tumor |
|
|
280 | (2) |
|
|
Fibroblastic Reticular Cell Tumor |
|
|
282 | (1) |
|
|
XIII Thymoma And Thymic Carcinoma |
|
|
283 | (6) |
|
|
284 | (3) |
|
|
|
287 | (2) |
|
Index |
|
289 | |